Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 3 trial of D-PLEX for prevention of sternal wound infection after cardiac surgery
MOH_2020-03-03_008747Phase 3Recruiting
- Sponsor
- PolyPid Ltd.
- Start
- Aug 2019
- Modality
- Small Molecules, Biodegradable Polymers → Polymer-based Nanoparticles → Nanoparticles → Drug Delivery Systems
- Countries
- 1
01
Overview
Phase 3, randomised, single-blind trial of D-PLEX100 in sternal wound infection (2 arms), sponsored by PolyPid Ltd. Primary endpoint: Primary efficacy endpoint. Started Aug 2019; status: recruiting.
02
Drugs
D-PLEX100
03
Conditions
sternal wound infection
Beyond the preview
Go deeper on MOH_2020-03-03_008747.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on MOH_2020-03-03_008747.